Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

4DMedical Ltd (4DX) Share Price & Analysis

226 Followers

4DX Stock Chart & Stats

A$2.35A$0.01(3.07%)
At close: 4:00 PM GMT+11
AU$2AU$3AU$4Aug 17Aug 31Sep 14Sep 28Oct 12Oct 26Nov 9
Day’s Range
AUD 2.23 - AUD 2.44
52-Week Range
AUD 1.40 - AUD 7.55
Previous Close
AUD 2.28
Volume
N/A
Average Volume (3M)
5.29M
Market Cap
AUD 1.42B
Enterprise Value
AUD 2.44B
Total Cash (Recent Filing)
AUD 277.95M
Total Debt (Recent Filing)
AUD 3.22M
Price to Earnings (P/E)
―
Beta
2.25
Next Earnings
Feb 26, 2027 (Est.)
EPS Estimate
-0.03
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Strong Revenue Growth

The sharp 2026 revenue increase shows that 4DMedical is expanding commercial activity and gaining adoption for its offerings. If this growth continues, greater scale could improve operating leverage, support investment in product development, and strengthen the company’s position in respiratory healthcare technology.

Low Financial Leverage

Very low leverage reduces balance-sheet risk and preserves flexibility while the company works toward profitability. A sizable equity base provides greater capacity to fund operations and strategic investment than a highly indebted structure, although continued losses could still erode this support over time.

Specialized Respiratory Technology

4DMedical operates in a specialized medical-technology niche combining respiratory imaging with software-based lung-function assessment. Its products address diagnosis, monitoring, management, and research applications, giving the business multiple healthcare use cases around a focused clinical technology platform.

Bears Say

Persistent Operating Losses

Sustained operating losses show that revenue growth has not yet translated into a viable earnings model. Continued negative margins can require ongoing external funding, limit strategic flexibility, and make it harder for the company to demonstrate that its commercial expansion will produce durable shareholder returns.

Ongoing Cash Burn

Persistent operating and free-cash-flow deficits mean the business continues to consume cash to fund operations rather than generate internal financing. Even with moderated burn in 2026, the ongoing funding requirement can constrain investment choices and increase pressure to raise capital before profitability is reached.

2026 Gross Profit Deterioration

A negative gross profit outcome indicates that reported revenue was not sufficient to cover the underlying cost of sales during 2026. Whether driven by heavy cost pressure or one-off impacts, this deterioration weakens confidence in near-term margin sustainability and delays the path toward operating profitability.

4DMedical Ltd News

4DX FAQ

What was 4DMedical Ltd’s price range in the past 12 months?
4DMedical Ltd lowest share price was AU$1.40 and its highest was AU$7.55 in the past 12 months.
What is 4DMedical Ltd’s market cap?
4DMedical Ltd’s market cap is AU$1.42B.
When is 4DMedical Ltd’s upcoming earnings report date?
4DMedical Ltd’s next earnings report is estimated for Feb 26, 2027 (not yet confirmed), which is in 106 days.
How were 4DMedical Ltd’s earnings last quarter?
4DMedical Ltd released its earnings results on Aug 28, 2026. The company reported AU$0.229 earnings per share for the quarter, beating the consensus estimate of -AU$0.04 by AU$0.269.
Is 4DMedical Ltd overvalued?
According to Wall Street analysts 4DMedical Ltd’s price is currently Undervalued.
Does 4DMedical Ltd pay dividends?
4DMedical Ltd does not currently pay dividends.
What is 4DMedical Ltd’s EPS estimate?
4DMedical Ltd’s EPS estimate is -0.03.
How many shares outstanding does 4DMedical Ltd have?
4DMedical Ltd has 602,339,500 shares outstanding.
What happened to 4DMedical Ltd’s price movement after its last earnings report?
4DMedical Ltd reported an EPS of AU$0.229 in its last earnings report, beating expectations of -AU$0.04. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of 4DMedical Ltd?
Currently, no hedge funds are holding shares in AU:4DX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology